Race executes global license agreement with City of Hope to access FTO IP
- Written by PR Newswire
- Race executes worldwide license agreement with City of Hope, one of the largest cancer research and treatment organisations in the United States.
- Under the agreement, Race will exclusively secure rights to a City of Hope patent application and associated know-how identifying that bisantrene may be the most potent inhibitor of the FTO pathway.
- Ag...
Read more: Race executes global license agreement with City of Hope to access FTO IP
